Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients Fisher, G. A., Lakhani, N. J., Eng, C., Hecht, J., Bendell, J. C., Philip, P., O'Dwyer, P. J., Johnson, B., Kardosh, A., Ippolito, T. M., Wang, Y. V., Agoram, B., Volkmer, J., Maute, R., Chico, I., Chao, M., Takimoto, C. M., Patnaik, A. AMER SOC CLINICAL ONCOLOGY. 2020
View details for Web of Science ID 000530922700108